Medical International Technology Inc. "MIT" announces that it has completed its 10QSB quarterly reports and has become up to date with its filings
Medical International Technology Inc. is pleased to continue providing asafe and effective means to help prevent the spread of deadly diseases to bothhumans and animals through the use of the MED-JET(R) and AGRO-JET(R)needle-free injection systems.
Karim Menassa, President
On Behalf of the Board of Directors
About Medical International Technology, Inc. MIT CANADA, with offices inMontreal, is a subsidiary of Denver, Colorado-based Medical InternationalTechnology, Inc. (MIT USA), which specializes in the development, production,marketing and sale of needle-free injectors both for humans and animals, forindividual and mass vaccinations.
The statements which are not historical facts contained in this pressrelease are forward-looking statements that involve certain risks anduncertainties, including but not limited to risks associated with theuncertainty of future financial results, additional financing requirements,development and acquisition of new product lines and services, governmentapproval processes, the impact of competitive products or pricing atechnological changes, the effect of economic conditions and otheruncertainties, and the risk factors set forth from time to time in theCompany's SEC reports, including but not limited to its annual report on Form10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K.Medical International Technology Inc. takes no obligation to update or correctforward-looking statements.
SOURCE MEDICAL INTERNATIONAL TECHNOLOGIES INC.
You May Also Like